Documentos relacionados

1. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
2. Can systematic reviews contribute to regulatory decisions?
3. Traceability and control as levers to prevent leakage from legal circulation when legalizing medical cannabis.
4. What impact could the legalisation of recreational cannabis have on the health of the UK? Lessons from the rest of the world.
5. Exploring the science-policy interface.
6. Taking the cat-and-mouse game to the next level: different perspectives on the introduction of the German New Psychoactive Substances Act.
7. The Modernization of Cosmetics Regulation Act of 2022: What dermatologists need to know.
8. The rise of new psychoactive substances and psychiatric implications: A wide-ranging, multifaceted challenge that needs far-reaching common legislative strategies.
9. Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine.
10. Regulators need to rethink restrictions on cannabis research.